Eye Drop Recall | EzriCare & Deslam Bacterial Infection Risk

The Lyon Firm has experience handling product recall cases and has filed a wide variety of product liability lawsuits on behalf of plaintiffs nationwide. The Firm is currently investigating eye drop recall injury claims.

Due to dozens of alleged bacterial eye infections, an eye drop recall has been issued by Global Pharma Healthcare (EzriCare and Deslam) for their artificial tears products.

A cluster of eye infections has reportedly resulted in vision loss, hospitalization and at least one death. The U.S. Food and Drug Administration (FDA) posted the Global Pharma recall and noted potential drug-resistant infection risk.

Most of the patients with infections in a CDC investigation reported using artificial tears. At least 55 cases in 12 states have been reported, dating back to May 2022.

EzriCare said customers should stop using its lubricating eye drops. Delsam Pharma, the other eye drop brand manufactured by Global Pharma Healthcare, said they are following the FDA recall request even though the CDC hasn’t linked Delsam’s eye drops to its investigation.

These artificial tear products are often used for treating dry eyes. Preservative-free eye drops like the ones being recalled have fewer additives that work to prevent bacteria growth.

Symptoms of a concerning eye infection may include discharge from the eye, eye pain, redness, irritation, increased sensitivity to light and blurry vision.

If you have used a Global Pharma product included in the eye drop recall, including EzriCare or Deslam, and suffered from an infection, contact the Lyon Firm to investigate.